107 related articles for article (PubMed ID: 10371085)
1. Actions of benzodiazepines and the benzodiazepine antagonist flumazenil may involve adenosine.
Stone TW
J Neurol Sci; 1999 Mar; 163(2):199-201. PubMed ID: 10371085
[TBL] [Abstract][Full Text] [Related]
2. The role of adenosine in the central actions of the benzodiazepines.
Phillis JW; O'Regan MH
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):389-404. PubMed ID: 2900536
[TBL] [Abstract][Full Text] [Related]
3. The suppression of hippocampal potentials by the benzodiazepine antagonist Ro 15-1788 may be mediated by purines.
Stone TW
Brain Res; 1986 Aug; 380(2):379-82. PubMed ID: 3019469
[TBL] [Abstract][Full Text] [Related]
4. Endogenous ligands of benzodiazepine binding site have inverse agonistic properties.
Sliva J; Hess L; Votava M; Malek J
Med Hypotheses; 2013 Dec; 81(6):1075-7. PubMed ID: 24183322
[TBL] [Abstract][Full Text] [Related]
5. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.
Weinbroum AA; Flaishon R; Sorkine P; Szold O; Rudick V
Drug Saf; 1997 Sep; 17(3):181-96. PubMed ID: 9306053
[TBL] [Abstract][Full Text] [Related]
6. [Flumazenil].
Iseki K
Chudoku Kenkyu; 2008 Oct; 21(4):373-8. PubMed ID: 19069130
[No Abstract] [Full Text] [Related]
7. Adenosine's role in the central actions of the benzodiazepines.
Phillis JW
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):495-502. PubMed ID: 6152338
[TBL] [Abstract][Full Text] [Related]
8. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
9. Review of the clinical pharmacology and use of the benzodiazepines.
Borchardt M
J Perianesth Nurs; 1999 Apr; 14(2):65-72. PubMed ID: 10418415
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
11. Interactions between benzodiazepine antagonists, inverse agonists, and acute behavioral effects of ethanol in mice.
Syapin PJ; Jones BL; Kobayashi LS; Finn DA; Alkana RL
Brain Res Bull; 1990 May; 24(5):705-9. PubMed ID: 2162723
[TBL] [Abstract][Full Text] [Related]
12. [Experience in the use of a benzodiazepine antagonist, flumazenil].
Vabishchevich AV; Buniatian AA; Stamov VI; Kochneva ZV
Anesteziol Reanimatol; 1997; (5):95-8. PubMed ID: 9432903
[TBL] [Abstract][Full Text] [Related]
13. The effects of flumazenil in neuropsychiatric disorders.
Malizia AL; Nutt DJ
Clin Neuropharmacol; 1995 Jun; 18(3):215-32. PubMed ID: 8635180
[TBL] [Abstract][Full Text] [Related]
14. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.
Brot MD; Akwa Y; Purdy RH; Koob GF; Britton KT
Eur J Pharmacol; 1997 Apr; 325(1):1-7. PubMed ID: 9151931
[TBL] [Abstract][Full Text] [Related]
15. [Effect of a specific benzodiazepine antagonist RO 15-1788 on phenazepam-induced inhibition of the evoked potentials in hippocampal neurons].
Glushankov PG; Skrebitskiĭ VG
Biull Eksp Biol Med; 1983 Nov; 96(11):65-7. PubMed ID: 6315108
[TBL] [Abstract][Full Text] [Related]
16. Bud extracts from Tilia tomentosa Moench inhibit hippocampal neuronal firing through GABAA and benzodiazepine receptors activation.
Allio A; Calorio C; Franchino C; Gavello D; Carbone E; Marcantoni A
J Ethnopharmacol; 2015 Aug; 172():288-96. PubMed ID: 26144285
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole.
Dawson GR; Curnow R; Bayley P; Rambridge A; Tricklebank MD
Eur J Pharmacol; 1994 Feb; 252(3):325-8. PubMed ID: 7909294
[TBL] [Abstract][Full Text] [Related]
18. The role of flumazenil in outpatient transesophageal echocardiography.
Tsang TS; Martin ML; Bailey KR; Seward JB
Clin Cardiol; 1999 Oct; 22(10):630-2. PubMed ID: 10526686
[TBL] [Abstract][Full Text] [Related]
19. F 2692: flumazenil-reversible anxiolytic effects but inactive on [3H]-Ro 15-4513 binding.
File SE; Andrews N
Pharmacol Biochem Behav; 1994 May; 48(1):223-7. PubMed ID: 7913225
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like properties of fominoben.
Crawley JN; Blumstein LK; Baldino F
Eur J Pharmacol; 1984 Jan; 97(3-4):277-81. PubMed ID: 6142823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
